Hannah Lewis
About Hannah Lewis
Hannah Lewis serves as the Patient Operations Manager at Sanguine, where she has worked since 2020, focusing on patient recruitment and sample collection for research studies. She previously held the position of Clinical Research Coordinator at Massachusetts General Hospital and has contributed to significant projects, including COVID-19 vaccine development.
Work at Sanguine
Hannah Lewis has served as the Patient Operations Manager at Sanguine since 2020. In this role, she collaborates with pharmaceutical and biotech companies to streamline direct-to-patient recruitment and sample collection processes. Her work is integral to enhancing patient engagement and operational efficiency within clinical research. Lewis has played a significant role in advancing COVID-19 vaccine development through Sanguine's innovative in-home patient specimen collection program. She has also contributed to the successful completion of over 600 research studies across a variety of medical conditions.
Previous Experience at Massachusetts General Hospital
Before joining Sanguine, Hannah Lewis worked as a Clinical Research Coordinator at Massachusetts General Hospital for a brief period in 2019. During her time there, she gained valuable experience in managing clinical research projects and supporting patient interactions. This role provided her with insights into the complexities of clinical trials and the importance of patient-centered approaches in research.
Education and Expertise
Hannah Lewis earned her Bachelor's degree in Biology/Biological Sciences from the University of Vermont, where she studied from 2015 to 2019. This educational background has equipped her with a solid foundation in biological sciences, which is essential for her current role in patient operations and clinical research. Her academic training supports her expertise in managing patient interactions and understanding the scientific aspects of clinical studies.
Contributions to Clinical Research
Throughout her career, Hannah Lewis has been actively involved in various aspects of clinical research. At Sanguine, she has contributed to the advancement of numerous research studies, particularly in the context of COVID-19 vaccine development. Her efforts in facilitating patient recruitment and specimen collection have been crucial in supporting the completion of over 600 research studies, reflecting her commitment to improving clinical research outcomes.